Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw

Journal of Oral and Maxillofacial Surgery

Volumn 69, Issue 2, 2011, Pages 362-380

  Hoefert, Sebastian ^a   Eufinger, Harald ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CEFACLOR; CEFAZOLIN; CEFOTAXIME; CEFUROXIME; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; CLODRONIC ACID; DOXYCYCLINE; FLUCONAZOLE; IBANDRONIC ACID; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PAMIDRONIC ACID; SULTAMICILLIN; ZOLEDRONIC ACID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAW OSTEONECROSIS; LONG TERM CARE; MALE; PREOPERATIVE CARE; SHORT COURSE THERAPY; SOFT TISSUE; TREATMENT DURATION; WOUND HEALING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; BONE DENSITY CONSERVATION AGENTS; CHLORHEXIDINE; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; JAW DISEASES; MALE; MIDDLE AGED; MOUTHWASHES; OSTEONECROSIS; OSTEOTOMY; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; SUCTION; SULBACTAM; SUTURE TECHNIQUES; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 78751585311     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2010.06.200     Document Type: Article

References (52)

1. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic J Oral Maxillofac Surg 61 2003 1115
2. M.R. Allen, and D.B. Burr The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypothesis, so few data J Oral Maxillofac Surg 67 2009 61
3. S. Hoefert, I. Schmitz, A. Tannapfel, and H. Eufinger Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: A possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings Clin Oral Investig 14 2010 271
4. S.L. Ruggiero, T.B. Dodson, and L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws2009 update J Oral Maxillofac Surg 67 suppl 2009 2
5. R. Landesberg, M. Cozin, and S. Cremers Inhibition of oral mucosal cell wound healing by bisphosphonates J Oral Maxillofac Surg 66 2008 839
6. S.L. Ruggiero, and S.J. Drew Osteonecrosis of the jaws and bisphosphonate therapy J Dent Res 86 2007 1013
7. R.G. Font, M.L.M. Garcia, and J.M.O. Martinez Osteochemonecrosis of the jaw due bisphosphonate treatments Update Med Oral Patol Oral Cir Bucal 13 2008 E318
8. R.M. Allen, D.J. Kubek, and D.B. Burr Cancer treatment dosing regimes of zoledronate acid result in near complete suppression of mandible intra-cortical bone remodeling in beagle dogs J Bone Miner Res 25 2009 98
9. M.R. Allen, and D.B. Burr Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment J Oral Maxillofac Surg 66 2008 987
10. T. Hansen, M. Kunkel, A. Weber, and C.J. Kirkpatrick Osteonecrosis of the jaws in patients treated with bisphosphonatesHistomorphologic analysis in comparison with the infected osteoradionecrosis J Oral Pathol Med 35 2006 155
11. A. Alonci, A. Allegra, and G. Bellomo Patients with bisphosphonate- associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1 Leuk Lymphoma 48 2007 1852
12. P. Lesclous, S. Abi Najm, and J.P. Carrel Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation? Bone 45 2009 843
13. S. Hoefert, W. Wierich, H. Eufinger, and B. Krempien BP-associated avascular necrosis (AN) of the jaws: histological findings Bone 38 suppl 2006 76
14. G. Favia, G.P. Pilolli, and E. Maiorano Histologic and histomorphometric features of bisphosphonate related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopy Bone 45 2009 406
15. D.K. Lam, G.K. Sandor, and H.I. Holmes A review of bisphosphonate- associated osteonecrosis of the jaws and its management J Can Dent Assoc 73 2007 417
16. J.W. Hellstein, and C.L. Marek Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63 2005 682
17. S. Khosla, D. Burr, and J. Cauley Bisphosphonate-associated osteonecrosis of the jaw: Report of the task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479
18. American Dental Association Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations J Am Dent Assoc 137 2006 1144
19. E.R. Carlson, and J.D. Basile The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 85
20. G. Tirelli, M. Biasotto, and S. Chiandussi Bisphosphonate-associated osteonecrosis of the jaws: The limits of a conservative approach Head Neck 31 2009 1249
21. S.L. Ruggiero, J. Fantasia, and E. Carlson Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 2006 433
22. P. Stockmann, E. Vairaktaris, and F. Wehrhan Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: A prospective clinical study with 12 months follow-up Support Care Cancer 18 2010 449
23. P. Vescovi, M. Manfredi, E. Merigo, and M. Meleti Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 66 2008 831
24. M.C. Adornato, I. Morcos, and J. Rozanski The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors J Am Dent Assoc 138 2007 971
25. R.P. Harper, and E. Fung Resolution of bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)] J Oral Maxillofac Surg 65 2007 573
26. A. Agrillo, C. Ungari, and F. Filiaci Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis J Craniofac Surg 18 2007 1071
27. P. Vescovi, E. Merigo, M. Meleti, and M. Menfredi Bisphosphonate- associated osteonecrosis (BON) of the jaws: A possible treatment? J Oral Maxillofac Surg 64 2006 1460
28. C. Pautke, F. Bauer, and T. Tischer Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 471
29. T. Van den Wyngaert, T. Claeys, and M.T. Huizing Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome Ann Oncol 20 2008 331
30. K. Alons, S.C.C. Kuijpers, E. De Jong, and J.P.R. Van Merkesteyn Treating low- and medium potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: A report of 7 cases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 E1
31. D. Srinivasan, S. Shetty, and D. Ashworth Orofacial paina presenting symptom of bisphosphonate associated osteonecrosis of the jaws Br Dent J 203 2007 91
32. O. Kanat, A. Ozet, and S. Ataergin Bisphosphonate treatment as a cause of jaw osteonecrosis Oral Dis 13 2007 346
33. K. Zervas, E. Verrou, and Z. Teleioudis Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: A single-centre experience in 303 patients B J Haematol 134 2006 620
34. D. Stanton, and E. Balasanian Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: Review of 33 surgical cases J Oral Maxillofac Surg 67 2009 943
35. S. Otto, S. Hafner, and K. Grtz The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw J Oral Maxillofac Surg 67 2009 589
36. P. Vescovi, M. Manfredi, and E. Marigo Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT) Lasers Med Sci 25 2010 101
37. K. Mitsimponas, M. Sereti, and T. Semergidis Bisphosphonate associated osteonecrosis: role of surgery J Craniomaxillofac Surg 36 suppl 2008 33
38. A.W. Eckert, P. Maurer, and L. Meyer Bisphosphonate-related jaw necrosisSevere complication in maxillofacial surgery Cancer Treat Rev 33 2007 58
39. G. Millesi, A. Wutzl, and E. Biedermann Bisphosphonate induced osteonecrosis of the jaws (BIONJ): Six months follow up J Oral Maxillofac Surg 11 2007 1043
40. M.H. Abu-Id, and P. Warnke Chirurgische Therapien der Bisphosphonat-assoziierten Kiefernekrosen (BONJ) Dtsch Zahnrztl Z 63 2008 D17
41. R. Diego, O. Drto, and D. Pagani Bisphosphonate-associated osteonecrosis of the jaws: A therapeutic dilemma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 2007 E1
42. F. Wilde, M. Heufelder, B. Frerich, and A. Hemprich Bisphosphonate associated osteonecrosis of the jaw: A successful treatment concept Int J Oral Maxillofac Surg 11 2007 1043
43. G. Ficarra, F. Beninati, and I. Rubino Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment J Clin Periodontol 32 2005 1123
44. G. Longobardi, R. Boniello, and G. Gasparini Surgical therapy for osteonecrotic lesions of the jaws in patients in therapy with bisphosphonates J Craniofac Surg 18 2007 1013
45. A. Wutzl, E. Biedermann, and F. Wanschitz Treatment results of bisphosphonate-related osteonecrosis of the jaws Head Neck 30 2008 1224
46. J. Katz, T. George, and P. Sandow Bisphosphonate-induced osteonecrosis of the jaw: Long-term outcomes J Support Oncol 7 2009 9
47. R.A. Williamson Surgical management of bisphosphonate induced osteonecrosis of the jaw Int J Oral Maxillofac Surg 39 2010 251
48. K. Wannfors, and L. Hammarstrm Infectious foci in chronic osteomyelitis of the jaws Int J Oral Surg 14 1985 493
49. P.P. Sedghizadeh, S.K.S. Kumar, and A. Gorur Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy J Oral Maxillofac Surg 66 2008 767
50. J. Bagan, J. Blade, and J.M. Cozar Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates Med Oral Pathol Oral Bucal 12 2007 E336
51. V. Montefusco, F. Gay, and F. Spina Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple treated with bisphosphonates Leuk Lymphoma 49 2008 2156
52. T.A. Rousan, I.T. Aldoss, and B. Cowley Recurrent acute thrombocytopenia in the hospitalized patient: Sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia Am J Hematol 85 2010 71